BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30726666)

  • 1. Neuropeptide PEN and Its Receptor GPR83: Distribution, Signaling, and Regulation.
    Mack SM; Gomes I; Devi LA
    ACS Chem Neurosci; 2019 Apr; 10(4):1884-1891. PubMed ID: 30726666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Neuropeptide PEN a Ligand of GPR83?
    Giesecke Y; Asimi V; Stulberg V; Kleinau G; Scheerer P; Koksch B; Grötzinger C
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of GPR83 as the receptor for the neuroendocrine peptide PEN.
    Gomes I; Bobeck EN; Margolis EB; Gupta A; Sierra S; Fakira AK; Fujita W; Müller TD; Müller A; Tschöp MH; Kleinau G; Fricker LD; Devi LA
    Sci Signal; 2016 Apr; 9(425):ra43. PubMed ID: 27117253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric Disorders.
    Lueptow LM; Devi LA; Fakira AK
    Prog Mol Biol Transl Sci; 2018; 159():1-25. PubMed ID: 30340784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orphan neuropeptides and receptors: Novel therapeutic targets.
    Fricker LD; Devi LA
    Pharmacol Ther; 2018 May; 185():26-33. PubMed ID: 29174650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAM237A, rather than peptide PEN and proCCK56-63, binds to and activates the orphan receptor GPR83.
    Li HZ; Wang YF; Shao XX; Liu YL; Xu ZG; Wang SL; Guo ZY
    FEBS J; 2023 Jul; 290(13):3461-3479. PubMed ID: 36853120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the neuropeptide PEN receptor, GPR83, in the reward pathway: Relationship to sex-differences.
    Fakira AK; Peck EG; Liu Y; Lueptow LM; Trimbake NA; Han MH; Calipari ES; Devi LA
    Neuropharmacology; 2019 Oct; 157():107666. PubMed ID: 31199956
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Mack SM; Gomes I; Fakira AK; Duarte ML; Gupta A; Fricker L; Devi LA
    Mol Pharmacol; 2022 May; 102(1):29-38. PubMed ID: 35605991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extracellular N-terminal domain of G-protein coupled receptor 83 regulates signaling properties and is an intramolecular inverse agonist.
    Müller A; Leinweber B; Fischer J; Müller TD; Grüters A; Tschöp MH; Knäuper V; Biebermann H; Kleinau G
    BMC Res Notes; 2014 Dec; 7():913. PubMed ID: 25516095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gpr83 Tunes Nociceptor Function, Controlling Pain.
    Kim Y; Kim C; Lee H; Kim M; Zheng H; Lim JY; Yun HI; Jeon M; Choi J; Hwang SW
    Neurotherapeutics; 2023 Jan; 20(1):325-337. PubMed ID: 36352334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
    Ohno K; Sakurai T
    Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomolar range of FAM237B can activate receptor GPR83.
    Li HZ; Wang YF; Hu WF; Liu YL; Xu ZG; Guo ZY
    Amino Acids; 2023 Nov; 55(11):1557-1562. PubMed ID: 37689599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein coupled receptor 83 (GPR83) signaling determined by constitutive and zinc(II)-induced activity.
    Müller A; Kleinau G; Piechowski CL; Müller TD; Finan B; Pratzka J; Grüters A; Krude H; Tschöp M; Biebermann H
    PLoS One; 2013; 8(1):e53347. PubMed ID: 23335960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of hypothalamic orexin in drug addiction].
    Han J; Li YH; Bai YJ; Sui N
    Sheng Li Ke Xue Jin Zhan; 2007 Oct; 38(4):327-30. PubMed ID: 18232303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the NPGP receptor and identification of a novel short mRNA isoform in human hypothalamus.
    Laemmle B; Schindler M; Beilmann M; Hamilton BS; Doods HN; Wieland HA
    Regul Pept; 2003 Mar; 111(1-3):21-9. PubMed ID: 12609745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83.
    Müller A; Berkmann JC; Scheerer P; Biebermann H; Kleinau G
    PLoS One; 2016; 11(12):e0168260. PubMed ID: 27936173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addiction and arousal: alternative roles of hypothalamic peptides.
    de Lecea L; Jones BE; Boutrel B; Borgland SL; Nishino S; Bubser M; DiLeone R
    J Neurosci; 2006 Oct; 26(41):10372-5. PubMed ID: 17035520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, localization, and function of a novel avian hypothalamic neuropeptide, 26RFa, and its cognate receptor, G protein-coupled receptor-103.
    Ukena K; Tachibana T; Iwakoshi-Ukena E; Saito Y; Minakata H; Kawaguchi R; Osugi T; Tobari Y; Leprince J; Vaudry H; Tsutsui K
    Endocrinology; 2010 May; 151(5):2255-64. PubMed ID: 20308530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
    Hoyer D; Bartfai T
    Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding.
    Gomes I; Aryal DK; Wardman JH; Gupta A; Gagnidze K; Rodriguiz RM; Kumar S; Wetsel WC; Pintar JE; Fricker LD; Devi LA
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16211-6. PubMed ID: 24043826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.